GLP-1R (Glucagon-like peptide-1 receptor) is a G protein-coupled receptor that plays a key role in glucose homeostasis, by mediating the effects of the incretin hormone GLP-1 (glucagon-like peptide-1) on pancreatic beta cells, which results in insulin secretion. GLP-1R is also expressed in various other tissues including the brain, heart, lungs, and kidneys. It has been implicated in various physiological and pathophysiological processes such as energy metabolism, cardiovascular function, and inflammation.Several drugs that target GLP-1R have been developed for the treatment of type 2 diabetes, including GLP-1 receptor agonists such as exenatide, liraglutide, and dulaglutide, which stimulate GLP-1R signaling and enhance insulin secretion. GLP-1R antagonists have also been investigated for their potential use in the treatment of obesity and other metabolic disorders.